2494 related articles for article (PubMed ID: 19808591)
1. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
2. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction.
Roes SD; Kelle S; Kaandorp TA; Kokocinski T; Poldermans D; Lamb HJ; Boersma E; van der Wall EE; Fleck E; de Roos A; Nagel E; Bax JJ
Am J Cardiol; 2007 Sep; 100(6):930-6. PubMed ID: 17826372
[TBL] [Abstract][Full Text] [Related]
5. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
[TBL] [Abstract][Full Text] [Related]
9. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
[TBL] [Abstract][Full Text] [Related]
10. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
Boyé P; Abdel-Aty H; Zacharzowsky U; Bohl S; Schwenke C; van der Geest RJ; Dietz R; Schirdewan A; Schulz-Menger J
JACC Cardiovasc Imaging; 2011 Aug; 4(8):871-9. PubMed ID: 21835379
[TBL] [Abstract][Full Text] [Related]
11. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.
Yan AT; Shayne AJ; Brown KA; Gupta SN; Chan CW; Luu TM; Di Carli MF; Reynolds HG; Stevenson WG; Kwong RY
Circulation; 2006 Jul; 114(1):32-9. PubMed ID: 16801462
[TBL] [Abstract][Full Text] [Related]
13. Can QRS scoring predict left ventricular scar and clinical outcomes?
Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
15. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
17. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
[TBL] [Abstract][Full Text] [Related]
18. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
[TBL] [Abstract][Full Text] [Related]
19. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
[TBL] [Abstract][Full Text] [Related]
20. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
